H.R. 2883: Stop Stalling Access to Affordable Medications

117th Congress · introduced 2021-04-28 · Health · Latest: Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.

federal

Follow this bill, step by step

Where it came from: introduced 2021-04-28 · official record
Who proposed it: Rep. Jeffries, Hakeem S. [D-NY-8] · what a sponsor is
What happened next: no floor votes in our records yet. Why?
Where it stands now: Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9. Not final yet: this can still change. We check for updates every day.
If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

Stop Stalling Access to Affordable Medications

Plain summary

Stop Stalling Access to Affordable Medications This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

Stop Stalling Access to Affordable Medications

Source: Congressional Research Service summary (Introduced in House)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Jeffries, Hakeem S. [D-NY-8] · 8 cosponsors

Cost estimate: CBO cost estimate: Estimated Budgetary Effects of H.R. 2883, the Stop Stalling Access to Affordable Medications Act (2022-07-22)

Cosponsors on this site

Jerrold Nadler (D-NY), Burgess Owens (R-UT), Ted Budd (R-NC)

Sponsor's campaign money: Rep. Jeffries, Hakeem S. [D-NY-8] reported raising $17.9 million (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Words on this page, explained (1)

Bill: A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).

Plain meanings written from linked sources. All words.

Sources

Congressional Research Service summary (Introduced in House)
Congress.gov
Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-117hr2883.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr>

Record fed-us-cong117-hr2883 · catalog fed-us-congress-bills-cong117 · updated 2026-11-15 by psicol fed-bills-cong117